Multi-parameter Assessment of Platelet Inhibition and Its Stability During Aspirin and Clopidogrel Therapy
A. Anil Timur,Gurunathan Murugesan,Li Zhang,John Barnard,Deepak L. Bhatt,Kandice Kottke-Marchant
DOI: https://doi.org/10.1016/j.thromres.2014.04.023
IF: 10.407
2014-01-01
Thrombosis Research
Abstract:Introduction: Poor response to antiplatelet drugs is associated with adverse outcomes. We assessed platelet inhibition and its stability and tested correlation and agreement between platelet function assays.Methods: Peripheral blood from 58 patients on both aspirin and clopidogrel who underwent percutaneous coronary intervention (PCI) was collected at hospital discharge (visit-1) and at 30-90 days (visit-2). Platelet function was measured using light transmission aggregometry (LTA-AA and LTA-ADP), VerifyNow (R) (Aspirin; ARU and P2Y12; PRU), ex vivo TxB(2), urinary 11dhTxB(2), and VASP (PRI) assays. Data were analyzed as continuous, quartiles and binary. Patients were defined as aspirin poor responder (PR) with ARU = 550, LTA-AA maximum >= 20%, TxB2 >= 1 ng/ mL or 11dhTxB(2) >= 1,500 pg/mg of creatinine and as clopidogrel PR with PRU >= 240, PRU >= 208, LTA-ADP maximum >= 40%, PRI >= 50%, or PRI >= 66%.Results: Aspirin PR was 3-33% and clopidogrel PR was 10-35% in visit-1. LTA-AA, 11dhTxB2, and all clopidogrel-response measures showed correlation and agreement between visit-1 and visit-2. The highest agreement between two visits was revealed by PRU = 240 and PRI = 66% (PRU-k = 0.7, 95% CI = 0.47, 0.93; PRI-kappa = 0.69, 95% CI= 0.42, 0.95, p-values < 0.001). Comparison of platelet function assays in a single visit (visit-1) revealed a poor correlation between LTA-AA and 11dhTxB(2) assays and no agreement among aspirin-response assays. The highest correlation and agreement were obtained between VerifyNow (R) P2Y12 and VASP assays (rho = 0.7, p-value < 0.001 and PRU = 208-PRI-kappa = 0.41-0.42, 95% CI = 0.13, 0.69, p-values < 0.001).Conclusions: Platelet inhibition is stable during aspirin and clopidogrel treatment. Clopidogrel-response assays correlate and agree with each other better than aspirin-response assays. (c) 2014 Elsevier Ltd. All rights reserved.